Cargando…

Which biological and self-report measures of cannabis use predict cannabis dependency and acute psychotic-like effects?

BACKGROUND: Changes in cannabis regulation globally make it increasingly important to determine what predicts an individual's risk of experiencing adverse drug effects. Relevant studies have used diverse self-report measures of cannabis use, and few include multiple biological measures. Here we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Curran, H. Valerie, Hindocha, Chandni, Morgan, Celia J. A., Shaban, Natacha, Das, Ravi K., Freeman, Tom P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6541869/ https://www.ncbi.nlm.nih.gov/pubmed/30176957 http://dx.doi.org/10.1017/S003329171800226X

Ejemplares similares

Associations between cigarette smoking and cannabis dependence: A longitudinal study of young cannabis users in the United Kingdom
por: Hindocha, Chandni, et al.
Publicado: (2015)

Effects of cannabidiol on anandamide levels in individuals with cannabis use disorder: findings from a randomised clinical trial for the treatment of cannabis use disorder
por: Hua, Daniel Ying-Heng, et al.
Publicado: (2023)

Individual and combined effects of cannabis and tobacco on drug reward processing in non-dependent users
por: Hindocha, Chandni, et al.
Publicado: (2017)

Anatomy of a Joint: Comparing Self-Reported and Actual Dose of Cannabis and Tobacco in a Joint, and How These Are Influenced by Controlled Acute Administration
por: Hindocha, Chandni, et al.
Publicado: (2017)

Cannabis based medicines and cannabis dependence: A critical review of issues and evidence
por: Schlag, Anne K, et al.
Publicado: (2021)

Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: A randomised, double-blind, placebo-controlled study in cannabis users
por: Hindocha, Chandni, et al.
Publicado: (2015)

Effect of four-week cannabidiol treatment on cognitive function: secondary outcomes from a randomised clinical trial for the treatment of cannabis use disorder
por: Lees, Rachel, et al.
Publicado: (2023)

Do AKT1, COMT and FAAH influence reports of acute cannabis intoxication experiences in patients with first episode psychosis, controls and young adult cannabis users?
por: Hindocha, Chandni, et al.
Publicado: (2020)

The CannTeen Study: Cannabis use disorder, depression, anxiety, and psychotic-like symptoms in adolescent and adult cannabis users and age-matched controls
por: Lawn, Will, et al.
Publicado: (2022)

Medicinal use of cannabis based products and cannabinoids
por: Freeman, Tom P, et al.
Publicado: (2019)

Acute and chronic effects of cannabinoids on effort-related decision-making and reward learning: an evaluation of the cannabis ‘amotivational’ hypotheses
por: Lawn, Will, et al.
Publicado: (2016)

Cannabis Dampens the Effects of Music in Brain Regions Sensitive to Reward and Emotion
por: Freeman, Tom P, et al.
Publicado: (2017)

Salience attribution and its relationship to cannabis-induced psychotic symptoms
por: Bloomfield, M. A. P., et al.
Publicado: (2016)

Acute memory and psychotomimetic effects of cannabis and tobacco both ‘joint’ and individually: a placebo-controlled trial
por: Hindocha, C., et al.
Publicado: (2017)

Investigating the interaction between schizotypy, divergent thinking and cannabis use
por: Schafer, Gráinne, et al.
Publicado: (2012)

No Smoke without Tobacco: A Global Overview of Cannabis and Tobacco Routes of Administration and Their Association with Intention to Quit
por: Hindocha, Chandni, et al.
Publicado: (2016)

The neuropsychopharmacology of cannabis: A review of human imaging studies
por: Bloomfield, Michael A.P., et al.
Publicado: (2019)

The International Cannabis Toolkit (iCannToolkit): a multidisciplinary expert consensus on minimum standards for measuring cannabis use
por: Lorenzetti, Valentina, et al.
Publicado: (2021)

Co-Use, Simultaneous Use, and Mixing of Cannabis and Tobacco: A Cross-National Comparison of Canada and the US by Cannabis Administration Type
por: Chu, Alanna, et al.
Publicado: (2023)

AKT1 genotype moderates the acute psychotomimetic effects of naturalistically smoked cannabis in young cannabis smokers
por: Morgan, C J A, et al.
Publicado: (2016)

Psychotic Cannabis Withdrawal: A Clinical Case
por: Ramos, Berta, et al.
Publicado: (2022)

Adversity, cannabis use and psychotic experiences: evidence of cumulative and synergistic effects
por: Morgan, Craig, et al.
Publicado: (2014)

Cognitive impairment in first psychotic episodes: The role of cannabis
por: Boi, S., et al.
Publicado: (2021)

Individual and combined effects of acute delta-9-tetrahydrocannabinol and cannabidiol on psychotomimetic symptoms and memory function
por: Morgan, Celia J. A., et al.
Publicado: (2018)

Rates and correlates of cannabis-associated psychotic symptoms in over 230,000 people who use cannabis
por: Schoeler, Tabea, et al.
Publicado: (2022)

Opposite Cannabis-Cognition Associations in Psychotic Patients Depending on Family History
por: González-Pinto, Ana, et al.
Publicado: (2016)

Are cannabis-using and non-using patients different groups? Towards understanding the neurobiology of cannabis use in psychotic disorders
por: Sami, Musa Basseer, et al.
Publicado: (2018)

Clinical and biochemical parameters associated with substance-induced psychotic disorder: which differences between alcohol, cannabis and psychostimulants
por: Nosari, G., et al.
Publicado: (2023)

Examining the profile of high-potency cannabis and its association with severity of cannabis dependence
por: Freeman, T. P., et al.
Publicado: (2015)

Attenuated Psychotic Symptoms in Adolescents With Chronic Cannabis and MDMA Use
por: Wiedmann, Melina, et al.
Publicado: (2022)

Assessing the translational feasibility of pharmacological drug memory reconsolidation blockade with memantine in quitting smokers
por: Das, Ravi K., et al.
Publicado: (2015)

S99. CANNABIS USE, PSYCHOTIC-LIKE EXPERIENCES AND ABERRANT SALIENCE IN A SAMPLE OF BELGIAN STUDENTS
por: Bernardini, Francesco, et al.
Publicado: (2018)

T87. CHANGING RATES OF PAST-YEAR CANNABIS USE BY PEOPLE WITH A PSYCHOTIC DISORDER
por: Waterreus, Anna, et al.
Publicado: (2020)

S103. IS CANNABIS A RISK FACTOR FOR SUICIDE ATTEMPTS IN MEN AND WOMEN WITH PSYCHOTIC ILLNESS?
por: Waterreus, Anna, et al.
Publicado: (2018)

Association of Combined Patterns of Tobacco and Cannabis Use in Adolescence With Psychotic Experiences
por: Jones, Hannah J., et al.
Publicado: (2018)

The effect of COVID-19 pandemic on admissions for cannabis-induced psychotic disorder
por: Elias De Sousa, A., et al.
Publicado: (2022)

Avatar Intervention for cannabis use disorder in patients with psychotic and mood disorders
por: Giguère, S., et al.
Publicado: (2023)

Cannabidiol reverses attentional bias to cigarette cues in a human experimental model of tobacco withdrawal
por: Hindocha, Chandni, et al.
Publicado: (2018)

Public health monitoring of cannabis use in Europe: prevalence of use, cannabis potency, and treatment rates
por: Manthey, Jakob, et al.
Publicado: (2021)

Predicting Self-Medication with Cannabis in Young Adults with Hazardous Cannabis Use
por: Wallis, Dorothy, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7qqjsrva81ct0r1euhmofbvtis